AGP Executive Report
Last update: an hour agoImmunization & Public Health: Ontario is adding CAPVAXIVE® to its publicly funded adult pneumococcal immunization program, expanding access for eligible older adults. Clinical Research & Drug Updates: AbbVie reports positive phase 3 results for atogepant in menstrual migraine prevention, while new analyses highlight that PPV23 vaccination wasn’t clearly linked to lower cardiovascular risk and that GLP-1 success should be judged by metabolic quality, not just weight loss. Workplace Health & Negotiations: CUPE 5430 says it’s seen movement in Saskatchewan health-care bargaining after job-action support, including some monetary changes. Rare Disease Awareness: A Sudbury family shares its Rett syndrome story as Lumina’s diagnosis reshaped her life and care needs. Health System & Services: MedLegalPsych launches independent psychiatric assessment and IME services in Winnipeg for insurers, employers and disability case managers. Care Access & Safety: A nurse in Nunavut challenges a workers’ compensation denial after an ATV hit her, arguing she wasn’t supported during recovery. Wellness Industry: CHFA’s 2026 Industry Achievement Awards spotlight leaders across Canada’s health-food and wellness sector, including Mitsoh as Trailblazer Small Business winner.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
